Clinical trial Recruiting at 1 site Observational Ages 3 to 12

Wearable device for monitoring sleep apnea in children

Official title: Development of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea

Run by National Institutes of Health Clinical Center (CC) · NCT05052216 · Data updated 2026-11-12

This study is testing a new wearable device to see if it can help monitor oxygen levels in the brains and limbs of children with and without sleep apnea.

More Obstructive Sleep Apnea trials

Quick facts

Study typeObservational
Ages3 Years to 12 Years
SexAll
Enrollment120 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Locations1 site (Bethesda, Maryland)
StatusRecruiting
StartedAugust 25, 2022
Main results expectedJanuary 31, 2028
Study endsJanuary 31, 2028
Registry record updatedNovember 5, 2026
Trial IDNCT05052216 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 3-12 who either have obstructive sleep apnea or do not have the condition.

Probably not a fit

Patients with chronic or acute medical conditions that interfere with sleep studies or those outside the age range of 3-12 years may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate a wearable point-of-care device using near-infrared spectroscopy (NIRS) to monitor oxygen levels in the brain and limbs of children with and without obstructive sleep apnea (OSA). Participants aged 3-12 will be divided into two groups: those diagnosed with OSA and those without. The study will involve overnight monitoring sessions to compare NIRS data with traditional polysomnography measurements. The goal is to better understand the relationship between oxygen saturation and apnea events, potentially leading to improved monitoring techniques for pediatric OSA.

Why it matters

Potential benefit: If successful, this study could lead to enhanced monitoring and understanding of pediatric obstructive sleep apnea, improving patient outcomes.

How similar studies have gone: While the use of NIRS in sleep studies is emerging, this specific approach is novel and has not been extensively tested in pediatric populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

1. Male or female, aged \>=3 and \<13 years
2. For NORM group: Children without OSA (AHI\<2)
3. For OSA group: Children with OSA (AHI\>=2)

EXCLUSION CRITERIA:

An individual who meets any of the following criteria will be excluded from participation in this study:

1. Children \<3 years or \>=13 years
2. Any chronic or acute medical condition that in the opinion of the investigators will interfere with overnight sleep study acquisition.
3. Any head injuries or physical conditions that in the opinion of the investigators would affect probe signal and contact.
4. For NORM group: Children with AHI\>=2
5. For OSA group: Children with AHI\<2

Where it's running

  • National Institutes of Health Clinical Center
    Bethesda, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Bruce J Tromberg — Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • Study coordinator: Thien T Nguyen
  • Email: thien.nguyen4@nih.gov
  • Phone: (301) 814-7234

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.